I hold a joint position as Associate Professor of Infectious Disease Epidemiology and Dynamics at the London School of Hygiene & Tropical Medicine and Nagasaki University. My research area is vaccine impact modelling, with a focus on estimating the health, economic, and equity impact of vaccination programmes to support evidence-based decision-making on vaccination strategies in collaboration with partners and stakeholders at the global, regional, and national levels.

The vision of our Vaccine Value group is to improve vaccine equity. We conduct impact assessments of existing and new vaccines to inform vaccine policy across diverse contexts, geographies, and resource settings. Our vaccine value assessments are based on multiple criteria, including disease burden, health and economic impact of vaccination, benefit-risk assessment, equity, vaccine-preventable antimicrobial resistance, acceptability among stakeholders and the community, and broader socioeconomic benefits.

We welcome collaborations related to estimating the value of vaccination in diverse settings, and you are welcome to contact us.